2021 - Participating Startup Companies
AthenaX is a digital health platform designed to provide integrated cancer care to underserved patients. By providing rich, real-world data to biotechnology and pharmaceutical companies to increase patient engagement and decrease costs for clinical trials, our cognitive behavioral therapy approach will enable us to care for the whole patient. AthenaX will not only provide virtual supportive cancer care but also create personalized recommendations and serve each patient as their own digital health advocate, particularly for disadvantaged patients with lower socio-economic status, geographical location or lack of equity across racial disparities in healthcare. A key differentiator of our platform will be our partnership with pharmaceutical/biotech companies to customize our platform for their protocols to increase patient engagement, provide greater support and provide real-time monitoring.
AthenaX is a patient centric integrated care advocate, while providing clinically validated real world evidence to researchers and caregivers. Personalized behavioral recommendations during and after treatment leveraging medical records and real time activity provides an incentive for consistent engagement, avoiding a common issue of long-term adoption.
The clinical trial applications of AthenaX will support clinical trials through increased engagement, as AthenaX will provide personalized behavioral recommendations for patients based on live biomarkers, such as heart rate, sleep , activity, etc. This will be provided to researchers to help better capture real world evidence and ultimately support trial adherence to reach study endpoints. AthenaX will also be used in the hospital setting to be provided to cancer patients along with standard of care to be a virtual advocate providing behavior recommendations, educational content, health navigation and treatment transparency.